Biocon shares rise 2% after USFDA has concluded inspection with 5 observations

Biocon shares rose 2% to RS 364 on Friday 5 September, after the announcement of the company that the US Food and Drug Administration (FDA) has completed a routine good manufacturing practice (CGMP) -Specture (CGMP) on Biocon Biocon -Campance Facility in the Biocon -Campance Facility Observations. The Inspectorate, carried out between August 26 and September […]